Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Lotrisone
Synonyms :
betamethasone/clotrimazole
Class :
Topical Corticosteroids/Antifungals
Dosage Forms & Strengths
clotrimazole/betamethasone
cream
0.05%/1% (15g, 45g)
lotion
0.05%/1% (30mL)
Cream: Apply every 12hr to infected area for 1 week; after 1 week if there is no improvement; do not exceed more than 45g per week; for maximum of 2 weeks
Lotion: Apply every 12hr to infected area for 1 week; after 1 week if there is no improvement; do not exceed more than 45 g per week; for maximum of 2 weeks
Cream: Apply to infected area every 12hr for 1 week; after 1 week if there is no improvement; do not exceed more than 45 mL per week; for maximum of 4 weeks
Lotion: Apply to infected area every 12hr for 1 week; after 1 week if there no improvement; do not exceed more than 45 mL per week; for maximum of 4 weeks
Safety and efficacy not established
Refer to adult dosing
Actions and spectrum:
betamethasone is a corticosteroid that reduces inflammation, itching, and redness. It works by suppressing the immune system’s response to the irritation or infection.
clotrimazole is an antifungal medication that stops the growth of fungi, including yeasts and molds. It works by inhibiting the production of ergosterol, a component of the fungal cell membrane
Frequency defined:
1-10%
Dry skin (2%)
Local burning (2%)
Paresthesia (2%)
<1%
Edema
Skin atrophy
Skin ulceration
Bruising
Striae
Rash
Secondary infection
Acneiform eruption
Folliculitis
Frequency undefined
clotrimazole
Erythema
Blistering
Edema
Urticaria
Stinging
Peeling
Pruritus
General skin irritation
betamethasone
Burning
Irritation
Folliculitis
Acneiform eruptions
Perioral dermatitis
Skin maceration
Striae
HPA suppression
Itching
Dryness
Hypertrichosis
Hypopigmentation
Allergic contact dermatitis
Skin atrophy
Miliaria
Black box warning:
The prolonged use of betamethasone and clotrimazole may cause a range of serious side effects like skin thinning, adrenal suppression, increased intraocular pressure and increased risk of skin infections including bacterial, viral, and fungal infections.
Contraindication/Caution:
Contraindication
Caution
Comorbidities
Pregnancy consideration:
pregnancy category C
Lactation: safety and efficacy is established
Pregnancy category:
Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.
Category B: There is no evidence of risk to the fetus found in animal reproduction studies and there are not enough studies on pregnant women.
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for an effect in humans, care must be taken for potential risks in pregnant women
Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite potential risks may be used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh risks over benefits These category drugs should be prohibited for pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology:
betamethasone/clotrimazole is a combination medication that contains two active ingredients: betamethasone and clotrimazole. Betamethasone is a synthetic corticosteroid that works by reducing inflammation and suppressing the immune system, while clotrimazole works by inhibiting the growth and replication of fungal cells.
Pharmacodynamics:
betamethasone is a synthetic corticosteroid that works by reducing inflammation and suppressing the immune system. It binds to specific receptors in cells and modifies the expression of certain genes, which results in the inhibition of the production of various pro-inflammatory cytokines and chemokines. This leads to the reduction of inflammation, redness, and itching.
blotrimazole is an antifungal medication that works by inhibiting the growth and replication of fungal cells. It interferes with the synthesis of ergosterol, a key component of the fungal cell membrane. This leads to the disruption of the fungal cell membrane, which causes leakage of intracellular contents and eventual cell death.
Pharmacokinetics
Absorption:
betamethasone/clotrimazole is typically applied topically to the affected area, and absorption into the bloodstream is minimal. However, some absorption can occur, particularly with long-term use, or with the use of occlusive dressings.
Distribution:
Once absorbed, the medication is distributed throughout the body and metabolized in the liver. The metabolites are eliminated in the urine and feces.
Metabolism:
betamethasone is metabolized by the liver and excreted in the urine and feces, while clotrimazole is metabolized by the liver and excreted through feces.
Elimination:
The half-life of betamethasone is relatively short, approximately 36-54 hours, while the half-life of clotrimazole is longer, approximately 2 hours. The elimination half-life of the combination product is not well established, but it is likely the half-life of betamethasone.
Administration:
Patient information leaflet
Generic Name: betamethasone and clotrimazole
Pronounced: (bay-ta-meth-a-sone-and-kloe-trim-a-zole-top-ik-al)
Why do we use betamethasone/clotrimazole?
betamethasone/clotrimazole is a combination medication that is primarily used to treat skin conditions that involve both inflammation and fungal infections, such as tinea infections (ringworm), eczema, and psoriasis.
The medication combines the anti-inflammatory properties of betamethasone with the antifungal properties of clotrimazole to provide a dual approach to treating these conditions.